Substance Use Disorder
A bipartisan group of 13 senators yesterday urged Health and Human Services Secretary Alex Azar to initiate a rulemaking process to modernize 42 CFR Part 2 to allow safer, more effective and better-coordinated treatment for patients with substance use disorders.
The Substance Abuse and Mental Health Services Administration and National Association of State Mental Health Program Directors are working to create a registry of crisis intervention beds for people with serious mental illness, SAMHSA announced last week.
The Substance Abuse and Mental Health Services Administration today published tips for consumers seeking effective treatment for alcohol or drug addiction. The blog post by Anne Herron, acting director of the SAMHSA Center for Substance Abuse Treatment, highlights considerations ranging from…
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug Administration today released model consumer-friendly labels for prospective OTC versions of the drug.
The drug overdose death rate among U.S. women aged 30 to 64 years old increased 260 percent between 1999 and 2017, to 24.3 per 100,000 people.
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a recent report from the Centers for Disease Control and Prevention.
The Pain Management Best Practices Inter-Agency Task Force recently released for comment proposed updates to best practices for managing chronic and acute pain, as required by the Comprehensive Addiction and Recovery Act of 2016.
The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance in exchange for their service on the front lines of the opioid crisis in underserved communities.
Also in this weekly roundup of health care news: how mandated access to at-home palliative care has made all the difference for some patients; and a town’s first-person account of battling the opioid epidemic.
Clinicians should strongly consider prescribing or co-prescribing naloxone to certain patients at risk for opioid overdose, and educating them about its use, according to guidance released today by the Department of Health and Human Services.